A Review of Complications Due to the Use of Botulinum Toxin A for Cosmetic Indications

被引:50
作者
Sethi, Nitin [1 ]
Singh, Sukhbir [2 ]
DeBoulle, Koenraad [3 ]
Rahman, Eqram [4 ,5 ]
机构
[1] Fortis Hosp Ludhiana, Plast & Cosmet Surg, Ludhiana 141001, Punjab, India
[2] Resplendent Cosmet Studio, R-9,GK 1, New Delhi 110048, India
[3] Aalst Dermatol Clin, Aalst, Belgium
[4] UCL, Dept Plast & Reconstruct Surg, London NW3 2QG, England
[5] Royal Fre Hosp, London NW3 2QG, England
关键词
Botulinum toxin A; Wrinkles; Complication; NEUROTOXIN TYPE-A; LONG-TERM SAFETY; DOUBLE-BLIND; GLABELLAR LINES; ADVERSE-REACTIONS; HEMIFACIAL SPASM; PARALLEL-GROUP; OPEN-LABEL; PLACEBO; EFFICACY;
D O I
10.1007/s00266-020-01983-w
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Botulinum toxin A (botulinum toxin A) was found to provide a wide variety of therapeutic and aesthetic benefits as one of the most potent toxins in the world. Injectable remedies, including soft tissue fillers and botulinum toxin, have become very common in wrinkling and face rejuvenation management. While these methods of treatment are relatively safe, serious side effects can occur. In this review, the complications of BoNTA are highlighted. Methods A literature research considered published journal articles (clinical trials or scientific reviews). Electronic databases (PubMed, Scopus, Science Direct) were searched using key terms, and for identification of additional relevant studies, reference lists have also been examined. Only articles published in English were included in this review with a time restriction from 2000 to 2020. Results There are various injection-related adverse effects associated (AE) with botulinum toxins such as erythema, oedema, pain, ptosis of eyelid or brow and ecchymosis. The overall majority of adverse events identified are mild and temporary. Conclusion As the use of toxins becomes increasingly more common, adverse events can be expected to increase as well. The practitioners need to be aware of such AEs, and the patients should be informed of these before undertaking such procedures.
引用
收藏
页码:1210 / 1220
页数:11
相关论文
共 62 条
[1]   Severe, intractable headache after injection with botulinum A exotoxin: Report of 5 cases [J].
Alam, M ;
Arndt, KA ;
Dover, JS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (01) :62-65
[2]   A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines [J].
Ascher, B ;
Zakine, B ;
Kestemont, P ;
Baspeyras, M ;
Bougara, A ;
Santini, J .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (02) :223-233
[3]   Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Lateral Crow's Feet: Double-Blind, Placebo-Controlled, Dose-Ranging Study [J].
Ascher, Benjamin ;
Rzany, Berthold J. ;
Grover, Rajiv .
DERMATOLOGIC SURGERY, 2009, 35 (10) :1478-1486
[4]   The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review [J].
Awan, Kamran Habib .
SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (01) :18-24
[5]  
Bowler Patrick J, 2005, J Cosmet Dermatol, V4, P89, DOI 10.1111/j.1473-2165.2005.40207.x
[6]   Randomized, Placebo-Controlled Study of a New Botulinum Toxin Type A for Treatment of Glabellar Lines: Efficacy and Safety [J].
Brandt, Fredric ;
Swanson, Neil ;
Baumann, Leslie ;
Huber, Barbara .
DERMATOLOGIC SURGERY, 2009, 35 (12) :1893-1901
[7]   Cosmetic use of botulinum A exotoxin for the aging neck [J].
Brandt, FS ;
Bellman, B .
DERMATOLOGIC SURGERY, 1998, 24 (11) :1232-1234
[8]   Long-term prospective follow-up of botulinum toxin treatment for facial rhytides [J].
Bulstrode, NW ;
Grobbelaar, AO .
AESTHETIC PLASTIC SURGERY, 2002, 26 (05) :356-359
[9]   Report of Allergic Reaction After Application of Botulinum Toxin [J].
Careta, Mariana Figueiroa ;
Delgado, Livia ;
Patriota, Regia .
AESTHETIC SURGERY JOURNAL, 2015, 35 (05) :NP102-NP105
[10]   Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females [J].
Carruthers, A ;
Carruthers, J ;
Said, S .
DERMATOLOGIC SURGERY, 2005, 31 (04) :414-422